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Abstract
Background: A robust inflammatory response occurs in the hours and days following cerebral ischemia. However,
little is known about the immediate innate immune response in the first minutes after an ischemic insult in
humans. We utilized the use of circulatory arrest during cardiac surgery to assess this.
Methods: Twelve neonates diagnosed with an aortic arch obstruction underwent cardiac surgery with
cardiopulmonary bypass and approximately 30 minutes of deep hypothermic circulatory arrest (DHCA, representing
cerebral ischemia). Blood samples were drawn from the vena cava superior immediately after DHCA and at various
other time points from preoperatively to 24 hours after surgery. The innate immune response was assessed by
neutrophil and monocyte count and phenotype using FACS, and concentrations of cytokines IL-1β, IL-6, IL-8, IL-10,
TNFα, sVCAM-1 and MCP-1 were assessed using multiplex immunoassay. Results were compared to a
simultaneously drawn sample from the arterial cannula. Twelve other neonates were randomly allocated to
undergo the same procedure but with continuous antegrade cerebral perfusion (ACP).
Results: Immediately after cerebral ischemia (DHCA), neutrophil and monocyte counts were higher in venous
blood than arterial (P = 0.03 and P = 0.02 respectively). The phenotypes of these cells showed an activated state
(both P <0.01). Most striking was the increase in the ‘non-classical’ monocyte subpopulations (CD16intermediate;
arterial 6.6% vs. venous 14%; CD16+ 13% vs. 22%, both P <0.01). Also, higher IL-6 and lower sVCAM-1
concentrations were found in venous blood (both P = 0.03). In contrast, in the ACP group, all inflammatory
parameters remained stable.
Conclusions: In neonates, approximately 30 minutes of cerebral ischemia during deep hypothermia elicits an
immediate innate immune response, especially of the monocyte compartment. This phenomenon may hold
important clues for the understanding of the inflammatory response to stroke and its potentially detrimental
consequences.
Trial registration: ClinicalTrial.gov: NCT01032876
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Background
It is well established that cerebral ischemia induces an
immune response on many different levels. Both in the
parenchyma and the systemic circulation, within hours
after the insult, cytokines are produced in vast amounts
and leukocytes are activated and migrate into the injured
brain [1-5]. The various immune cells and their subpo-
pulations have very different effects on the lesion and
thus the outcome for the patient [6].
The exact mechanisms in the pathway from the cessa-
tion of blood flow to the establishment of stroke and its
outcome have predominantly been studied in animal
models. These have shown the infiltration of neutrophils
and monocytes into the cerebral tissue starting from 4 to
6 hours after the ischemic insult, with these cells showing
phenotypical changes in the periphery for weeks following
the event [2,3]. In adults with a cerebrovascular accident
or a transient ischemic attack, it is the systemic compart-
ment which has been studied most. Proinflammatory
cytokine concentrations have been associated with poor
neurological outcome after stroke, as have innate immune
cell numbers and phenotypes [7-9]. For example, Smith
et al. have found high TNFα and activated neutrophils to
be correlated to worse symptoms after stroke [9]. Others
have shown that monocytes are highly associated to prog-
nosis, with the different monocyte subpopulations having
variable effects, likely due to their specific characteristics
and functions [4]. For example, the abundance of ‘clas-
sical’ (CD16-) monocytes in the peripheral circulation fol-
lowing stroke were shown to be associated with a worse
outcome [8]. Data on the immune response to cerebral is-
chemia in neonates is scarce. There have been studies on
the effects of perinatal asphyxia, which show a burst in
cytokines and activation of neutrophils and monocytes
within 24 hours, similar to the response in adults [10-15].
Although many studies have characterized the im-
mune response to stroke in the hours and days after the
insult, the immediate effect of cerebral ischemia has
never been assessed. The unique opportunity to assess
this arises in the field of cardiac surgery, where proce-
dures performed with the use of cardiopulmonary bypass
(CPB) may include a period of global circulatory arrest
at a deep hypothermic temperature (‘deep hypothermic
circulatory arrest’, DHCA). This allows for the study of
the immediate response to approximately 30 minutes of
induced cerebral ischemia. We assessed the inflamma-
tion in the cerebral circulation by characterization of
neutrophils and monocytes and measurement of cyto-
kines IL-1β, IL-6, IL-8, IL-10, TNFα, sVCAM-1 and
MCP-1, as these markers are known to respond within
hours after cerebral ischemia [1,3,7,8,10-14,16-20]. The
results were compared to those from patients undergo-
ing the same surgical procedure at the same
temperature, but with continuous cerebral perfusion,
and thus without any apparent ischemia (‘antegrade
cerebral perfusion’, ACP). We hypothesized that DHCA
would have an immediate ‘proinflammatory’ effect on in-
nate immune cells and cytokines, whereas ACP would
not affect these markers of systemic inflammation.
Methods
Patients and surgical procedures
Neonates presenting with a hypoplastic aortic arch be-
tween 2009 and 2011 were assigned to undergo aortic
arch reconstruction. This procedure entails the use of ei-
ther DHCA or ACP during CPB. The current study was
performed as part of a prospective randomized controlled
trial comparing DHCA and ACP in terms of neurological
outcome (clinicaltrials.gov number NCT01032876). In the
subgroup reported here, data on cerebral inflammatory
markers were collected. Surgery and CPB was performed
as previously described [21]. The institutional medical eth-
ics committee approved the study and all parents gave
informed consent for enrollment.
Sample collection
Blood samples were drawn at various time points (see
Figure 1); 1) ‘preoperative’: before the start of CPB and
after the administration of dexamethasone 1 mg/kg to
the patient; 2) ‘Start of DHCA/ACP’: after cooling, at
deep hypothermia on full-flow CPB, just before the start
of either DHCA or ACP; 3) ‘End’: immediately (0 to
3 minutes) following DHCA or ACP; 4) ‘30 min reperfu-
sion’: 30 minutes after recommencement of full body
Figure 1 Sample collection during CPB. Upper picture shows all
time points at which blood samples were collected. The first was
before CPB (‘Pre-op’). Once on CPB, patients were cooled to deep
hypothermia and DHCA or ACP was initiated (‘Start’). At the end of
DHCA or ACP (‘End’), full-flow CPB was recommenced and the patient
was rewarmed to normothermia, during which the ‘30 min’ sample
was drawn. Four and 24 hours after surgery, the final samples were
collected (‘4 h post-operative’ and ‘24 h post-operative’). The lower
picture depicts the arterial and venous samples drawn at the ‘End’
time point. Samples were simultaneously drawn from the arterial and
venous cannulae, transporting blood to and from the brain,
respectively. ACP, antegrade cerebral perfusion; CPB, cardiopulmonary
bypass; DHCA, deep hypothermic circulatory arrest.
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CPB (during rewarming); 5) ‘4 h postoperative’: 4 hours
after the end of DHCA or ACP, with the patient off CPB
and on the intensive care unit; 6) ‘24 h postoperative’:
24 hours after surgery.
At the ‘Start DHCA/ACP’ time point (at deep
hypothermia, on full-flow CPB), leukocyte counts are lower
than before surgery, due to the expansion of the circulating
volume after connection to the CPB circuit. For better com-
parison with preoperative leukocyte counts, the count dur-
ing CPB at ‘Start’ was corrected for this dilution, based on
the volume of the CPB circuit. For example, a child of 3 kg
is expected to have 270 ml of circulating volume preopera-
tively, and when a CPB circuit volume of 810 ml is added,
the total circulating volume makes for a total volume of
1080 ml, hence a 4-times dilution. The leukocyte count at
‘Start’ can then be corrected for dilution by being multiplied
by 4 to attain the cell count corrected for dilution. The same
applies to the ‘End’ and ‘30 min’ time points. We depicted
these corrected counts in grey in Figure 2a and b.
At the ‘End’ time point, blood samples were drawn from
two different locations of the CPB circuit, named the ‘ar-
terial’ and ‘venous’ samples (see Figure 1). The arterial
sample represents blood going to the brain, whereas the
venous sample represents blood exiting the brain. The ar-
terial sample was drawn from the arterial line, which con-
nects the CPB machine to the aorta of the patient. The
venous sample was drawn from the venous cannula,
which is situated in the vena cava superior of the patient,
where the venae azygos and anonyma were temporarily
occluded in order to obtain blood specifically coming
from the brain, and the first 10 ml of blood was discarded
as it approximates the dead space of the cannula.
Laboratory analyses
Blood samples were kept on ice during all handling and
staining procedures. Plasma samples were analyzed by
multiplex immunoassay to measure levels of IL-1β, IL-6,
IL-8, IL-10, TNFα, sVCAM-1 and MCP-1 with the Bio-
Plex™ suspension array system (Bio-Rad Laboratories,
Hercules, CA, USA) as previously described [22]. Neu-
trophil and monocyte counts were performed by manual
microscopy; hematocrit and thrombocyte counts were
analyzed by an automated cell counter.
As shown in Figure 3, monocytes were categorized into
three monocyte subpopulations (CD16-, CD16intermediate
(CD16int), and CD16) as proposed by Ziegler-Heitbrock
et al. [23,24]. For neutrophil phenotyping, fluorescently la-
beled monoclonal antibodies (mAb) directed against
CD11b (RPE, clone 2LPM19c; Dako, Glostrup, Denmark)
and CD62L (FITC, clone Dreg56; BD Biosciences, Franklin
Lakes, New Jersey, USA) were used for flow cytometry. For
monocyte phenotyping, CD14 (Pacific Blue, 301815 clone
M5E2; BioLegend, San Diego, CA, USA), HLA-DR (PE,
347401; BD Biosciences), CD16 (APC, MHCD1605, clone
3 G8, CalTag Medsystems, Buckingham, UK) and CD62L
(FITC, 555543, clone Dreg 56; BD Biosciences), The FACS-
Canto flow cytometer (BD Biosciences) was used to record
cells and FacsDiva software (BD Biosciences), Facs Express
(De Novo software, Thornhill, ON, Canada) and FlowJo
(Ashland, OR, USA) software were used for analysis. Neu-
trophils were identified according to their specific forward-
and sideward-scatter signals. Expressions of CD11b and
CD62L were calculated as activational markers (with
CD11b increasing, and CD62L decreasing during
activation).
Figure 2 Monocyte subpopulations. (a) Gating of monocytes into CD16+, CD16int (intermediates) and CD16+ subpopulations. (b) CD16-
monocytes show a low expression of HLA-DR, whereas CD16int and CD16+ show a high expression (MFIs of 663 (IQR 337 to 867), 2174 (1189 to
4884) and 3903 (1372 to 8393), respectively). IQR, interquartile range; HLA-DR, human leukocyte antigen D-related; MFI, median fluorescence
intensity.
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Statistical analyses
Values in graphs and text are stated as numbers (% of popu-
lation) or medians (interquartile range (IQR)). Differences
between arterial and venous samples were tested using Wil-
coxon signed-rank test. Differences between DHCA and
ACP for time points from ‘30 min reperfusion’ onward were
tested by Mann–Whitney U test. IBM SPSS Statistics
version 19 (IBM Corp., Armonk, NY, USA) was used for
statistical calculations and Prism version 5.03 was used to
depict graphs (GraphPad Software, San Diego, CA, USA).
Results
Baseline characteristics
Data were collected from 24 neonates (n = 12 for DHCA,
n = 12 for ACP). All neonates underwent aortic arch recon-
struction as well as intracardiac procedures for specific
diagnoses listed in Table 1. Surgical and CPB data were
similar at the start of DHCA or ACP. Also, inflammatory
profiles were comparable preoperatively and at the start of
either DHCA or ACP, as shown in Table 2.
Deep hypothermic CPB decreases neutrophil and
monocyte counts
Cell numbers were available for all 24 neonates (n = 12
for both groups). Figure 2 shows the perioperative
change in neutrophil and monocyte counts for the
DHCA and ACP groups separately. In grey, the counts
during deep hypothermic, full-flow CPB are depicted,
corrected for the dilution of the CPB circuit. At 4 hours
after surgery, neutrophil and monocyte numbers are
back to their preoperative values and rise further at
24 hours.
Figure 3 Deep hypothermic CPB decreases neutrophil and monocyte counts. Perioperative time course of neutrophil and monocyte and
counts, in DHCA and ACP groups separately (DHCA; (a) and (c); ACP; (b) and (d)). During CPB, counts were corrected for the dilution of the CPB
circuit (shown in grey). ACP, antegrade cerebral perfusion; CPB, cardiopulmonary bypass; DHCA, deep hypothermic circulatory arrest.
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Cerebral ischemia increases neutrophils and monocyte
counts
To assess the direct effect of cerebral ischemia on
leukocyte concentrations, we compared the absolute cell
counts of the cerebral venous sample to the arterial sam-
ple, both obtained immediately after DHCA. Results are
depicted in Figure 4a, which shows significantly
increased neutrophil numbers in venous blood com-
pared to arterial (median arterial 1.6 × 109/L (IQR 1.0 to
2.2) vs. venous 1.9 × 109/L (1.4 to 2.1); P = 0.03).
Monocyte counts also showed an increase from arterial
to venous (median arterial 0.18 × 109/L (0.09 to 0.28) vs.
venous 0.30 × 109/L (0.21 to 0.38), P = 0.02). In neonates
with continuous cerebral perfusion (ACP), leukocyte
numbers did not change (neutrophils P = 0.72 and
monocytes P = 0.40; Figure 4b).
To rule out an effect of hyperviscosity on the
increased leukocyte number after cerebral ischemia,
hematocrit and thrombocyte numbers were compared in
arterial and venous blood. As shown in Figure 4c and d,
these were stable after both DHCA and ACP (DHCA:
hematocrit P = 0.07 and thrombocytes P = 0.15; ACP:
hematocrit P = 0.44 and thrombocytes P = 0.96).
Cerebral ischemia leads to an immediate activation of
neutrophils and monocytes
Next, we questioned whether neutrophils exiting the
cerebral circulation after ischemia were not only more
abundant, but also more activated.
To this end, we assessed neutrophil phenotype using
CD62L (which is shed during activation) and CD11b
(which increases during activation). As shown in
Figure 5a, after cerebral ischemia (i.e., DHCA), although
CD62L did not change (P = 0.48), CD11b did show a
small, but significant increase from arterial to venous
(arterial median fluorescence intensity (MFI) 341 (286 to
543), venous 382 (313 to 638); P <0.01). In continuous
cerebral perfusion (i.e., ACP), no changes in expression
of CD62L and CD11b were observed (CD62L P = 0.06,
CD11bb P = 0.26; see Figure 5b).
Furthermore, we assessed changes in the composition
of the monocyte compartment after cerebral ischemia.
As depicted in Figure 5c and d, after cerebral ischemia
(i.e.,, DHCA), the percentage of CD16-negative mono-
cytes decreased significantly in the venous sample com-
pared to arterial (median arterial 78% (IQR 67 to 88),
venous 57% (45 to 71), P <0.01; see Figure 5c). In con-
trast, the CD16intermediate and CD16+ populations





Male sex 8/12 (67) 9/12 (75)
Age at surgery (days) 9 (8–11) 12 (8–15)
Diagnosis:
Hypoplastic left/right heart syndrome or
complex
8 (67) 5 (42)
Aortic arch interruption/coarctation 3 (25) 5 (42)
Double outlet right ventricle or double inlet
left ventricle
1 (8) 2 (17)
Duration of cooling (minutes) 33 (20–43) 30 (28–36)












Values represent number (% of group) or medians (interquartile ranges). ACP,
antegrade cerebral perfusion; CPB, cardiopulmonary bypass; DHCA, deep
hypothermic circulatory arrest.
Table 2 Baseline inflammatory characteristics
Neutrophils and monocytes DHCA ACP
Preoperative
Monocyte count 1.6 (1.3–2.1) 1.9 (1.1–2.1)
% CD16- monocytes 83 (71–91) 74 (52–83)
% CD16int monocytes 7.0 (5.0-14) 12 (6.7–22)
% CD16+ monocytes 7.0 (4.5–15) 10 (5.5–22)
Neutrophil count 8.2 (5.7–10.6) 6.0 (5.4–8.8)
Neutrophil CD62L expression 166 (103–257) 294 (221–329)
Neutrophil CD11b expression 426 (264–717) 523 (265–685)
Start DHCA or ACP
Monocyte count 0.17 (0.09–0.32) 0.20 (0.13–0.27)
% CD16- monocytes 81 (70–86) 78 (66–85)
% CD16int monocytes 6.5 (3.5–9.0) 6.6 (3.7–8.6)
% CD16+ monocytes 14 (7.4–19) 14 (7.3–23)
Neutrophil count 1.4 (0.8–2.2) 1.0 (0.5–1.4)
Neutrophil CD62L expression 189 (104–262) 205 (146–288)
Neutrophil CD11b expression 519 (322–743) 673 (468–792)
Cytokines and chemokines
Start DHCA or ACP
IL-1β 0.18 (0.00-1.1) 0.18 (0.00-0.62)
IL-6 18 (1.0–21) 8.1 (2.3–16)
IL-8 7.2 (5.6–35) 5.3 (3.0–10)
IL-10 42 (9.7–61) 12 (6.3–32)
Values corrected for dilution
IL-1β 0.82 (0.72–18) 0.81 (0.78–12)
IL-6 59 (15–103) 36 (8.1–65)
IL-8 28 (18–67) 26 (11–65)
IL-10 105 (42–337) 74 (23–135)
Values represent medians (interquartile ranges). Neutrophil and monocyte
counts in 109/L, neutrophil expressions in median fluorescence intensity (MFI),
cytokine and chemokine concentrations in pg/ml. ACP, antegrade cerebral
perfusion; DHCA, deep hypothermic circulatory arrest.
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increased from arterial to venous, reflecting increased
monocyte activation (CD16intermediate, median arterial
6.6% (4.5 to 8.7), venous 14 (11 to 17); CD16+ median
arterial 13% (IQR 8.6 to 19), venous 22% (17 to 36); both
P <0.01). After ACP, monocyte subpopulations remained
unchanged (CD16-negative P = 0.57, CD16intermediate P =
0.48, CD16+: P = 0.51; see Figure 5d).
Cerebral ischemia increases IL-6, and decreases sVCAM-1
concentrations
To assess whether the proinflammatory profile of the
cells was also reflected in the soluble compartment,
cytokines and chemokines were measured in the first 18
neonates included in this study (n = 10 DHCA, n = 8
ACP). Figure 6 shows arterial and venous concentrations
Figure 4 Cerebral ischemia increases neutrophils and monocyte counts. (a) Immediately after cerebral ischemia (i.e., DHCA), neutrophil and
monocyte counts are increased in the venous sample compared to arterial (P = 0.03 and P = 0.02, respectively). (b) In continuous cerebral
perfusion (i.e., ACP) there is no difference in neutrophil and monocyte counts. (c) To rule out the effect of hyperviscosity in the venous sample
after cerebral ischemia, hematocrit and thrombocyte numbers were assessed revealing no difference after DHCA. (d) Also after ACP there is no
difference in hematocrit and thrombocyte number. ACP, antegrade cerebral perfusion; DHCA, deep hypothermic circulatory arrest.
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after DHCA and ACP. After cerebral ischemia (i.e.,
DHCA), IL-6 levels significantly increased from arterial
to venous (median arterial 16 pg/ml (0.6 to 22); venous
19 pg/ml (1.1 to 39); P = 0.03).
Furthermore, soluble VCAM-1 significantly decreased in
this group (median arterial 1.0 × 106 pg/ml (0.83 to 1.3 ×
106); vs. venous 0.8 × 106 pg/ml (0.8 to 9.4 × 106), P =
0.03). These cytokines did not show any change in concen-
tration in the ACP group (IL-6 P = 0.49; sVCAM-1 P =
0.26). Regarding the other cytokines IL-1β, IL-8, IL-10 and
MCP-1, these did not change significantly from arterial to
venous in either the DHCA or ACP group (DHCA, IL-1β
P = 0.08, IL-8 P= 0.17, IL-10 P= 0.31, MCP P = 0.37; ACP,
IL-1β P = 0.48, IL-8 P = 0.16, IL-10 P = 0.16, MCP P =
0.48). TNFα was below the detection threshold in all
patients.
Differences between DHCA and ACP subside at later time
points
As listed in Table 3, after 30 minutes of reperfusion,
there were no differences to be found in neutrophil and
monocyte count or phenotype between DHCA and
ACP. The same applies to 4 hours postoperatively, al-
though at 24 hours there was a slight difference in
monocyte subpopulations, with less CD16+ monocytes
in the DHCA group (P = 0.01).
Regarding cytokines and chemokines, absolute con-
centrations were much higher after surgery than during
surgery, but when the intraoperative values are corrected
for dilution, IL-6 values remain approximately stable.
When comparing the two groups, only at 4 hours post-
operatively was there a higher IL-8 concentration in the
DHCA group (P = 0.04), other cytokines were not sig-
nificantly different.
Discussion
In the present study, we observed that in neonates
undergoing cardiac surgery, cerebral ischemia during
deep hypothermia elicited an immediate inflammatory
response in the cerebral circulation. Not only were there
significant changes in the soluble milieu; neutrophils and
monocytes acquired an activated phenotype and were
even increased in number upon leaving the cerebral cir-
culation. This was not the case in the situation where
Figure 5 Cerebral ischemia leads to an immediate activation of neutrophils and monocytes. (a) After cerebral ischemia (i.e., DHCA), CD62L
expression is the same in arterial and venous blood, but CD11b expression is higher in the venous sample compared to arterial (P <0.01). (b)
After continuous cerebral perfusion (i.e., ACP), neutrophil CD11b and CD62L expressions remain stable. (c) After cerebral ischemia (DHCA), in the
venous sample, the proportion of monocytes that is CD16- is decreased compared to arterial, due to an increase in CD16intermediate and
CD16+ monocyte subpopulations (all P <0.01). (d) After continuous cerebral perfusion (ACP), the monocyte subpopulations remain unchanged.
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the brain was continuously perfused. This phenomenon
has not been reported on previously and may hold im-
portant clues for further research on the inflammatory
response to stroke.
Previous studies involving cerebral ischemia and in-
flammation, both in neonates and adults, have found
changes in peripheral immune cells within hours after
the ischemic insult [1,3,8,10-14,16]. In the same time
frame, leukocytes are reported to start their migration
into the ischemic lesion [2-4]. However, to our know-
ledge, the immediate effect of ischemia on the cerebral
circulation has not been assessed previously. There have
been reports of other models of ischemia in other organ
systems, for example in limb ischemia and reperfusion
during orthopedic surgery. These have found neutrophils
and monocytes to acquire a more activated phenotype
after approximately 30 minutes of ischemia [25,26]. In
contrast, during coronary bypass operations in adults,
less activated cells were observed distal to the ischemic
coronary region than proximally [27]. Here, we report
the opposite (more activated cells and increased cell
numbers leaving the ischemic brain), which may suggest
that this is an organ-specific effect.
The most striking finding in this study is the abun-
dance of ‘non-classical’ (CD16intermediate and CD16+)
monocytes in venous blood directly after cerebral ische-
mia. The concentration is much higher than the concen-
tration of cells in the arterial sample, which was drawn
simultaneously. The question arises as to where these
cells have come from. To systematically address this
question, a number of options are possible: 1) these cells
have undergone proliferation, 2) the venous sample has
a higher viscosity, which increases the concentration of
immune cells, and/or 3) cells have migrated from the
parenchyma into the intravascular compartment. The
first option (proliferation) seems highly unlikely in the
short period of half an hour that the increase was
observed. The second option, of a temporarily more vis-
cous venous sample, could be an option for example by
leakage of plasma into the cerebral parenchyma, or an
uptake of fluid by other cells. However, both hematocrit
and thrombocyte numbers show stable values and thus
argue against this. Therefore, the most valid explanation
would be that the cells have migrated into the intravas-
cular compartment, from elsewhere. The cells may have
come from the ‘perivascular space’, which is located out-
side of the endothelial cell layer and inside the parenchy-
mal basal membrane. Histopathologic studies of the
brain have revealed that the perivascular space contains
macrophages, neutrophils and possibly also lymphocytes
[6,28,29]. We hypothesize that the neutrophils and
monocytes migrate from their perivascular location, into
the vascular space and thereby are increased in the ven-
ous sample. The increased permeability of the blood–
brain barrier due to the cessation of blood flow may
facilitate the migration of cells into the circulation [30-
Figure 6 Cerebral ischemia increases IL-6, and decreases sVCAM-1 concentrations. (a) After cerebral ischemia (i.e., DHCA), serum IL-6 is
mildly increased, and sVCAM-1 decreased, in the venous sample compared to arterial (both P = 0.03). (b) After continuous cerebral perfusion
(ACP), all cytokine levels remain stable.
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32]. A similar phenomenon has been observed in models
of exercise, where within 30 minutes after infusion of
adrenaline, amongst others, the ‘nonclassical’ monocytes
(CD16intermediate and CD16+) are dramatically increased
in the systemic circulation [33]. In this case, the release
of these monocytes from the perivascular space is
thought to be a direct effect of adrenaline, whereas in
the current study, it seems plausible that the ischemia
has initiated this process. The phenomenon has also
been described in transendothelial models of monocyte
trafficking, where the specifically the nonclassical mono-
cyte populations ‘reverse-migrate’ from the tissue into
the vascular lumen [34].
The decreased concentrations of neutrophils and mono-
cytes during deep hypothermic CPB may play a role in the
above described perivascular phenomenon. As is depicted in
Table 3 Inflammatory results for later time points
Neutrophils and monocytes DHCA ACP P
30 min reperfusion
Monocyte count 0.13 (0.06-0.23) 0.12 (0.07-0.14) 0.76
% CD16- monocytes 68 (60–85) 74 (50–88) 0.84
% CD16int monocytes 7.4 (5.7-14) 6.1 (2.4-10) 0.36
% CD16+ monocytes 19 (9.2-33) 16 (6.0-43) 0.76
Neutrophil count 1.5 (1.2-1.9) 1.1 (0.7-1.7) 0.24
Neutrophil CD62L expression 193 (67–227) 187 (134–307) 0.44
Neutrophil CD11b expression 610 (469–816) 672 (508–926) 0.85
4 h postoperative
Monocyte count 3.1 (1.7-4.8) 2.0 (1.5-2.4) 0.15
% CD16- monocytes 86 (85–95) 87 (78–94) 0.74
% CD16int monocytes 6.8 (4.9-8.7) 7.5 (3.2-11) 0.72
% CD16+ monocytes 6.0 (1.7-8.5) 4.5 (2.4-9.9) 0.88
Neutrophil count 8.2 (6.0-10.2) 6.9 (4.8-8.5) 0.43
Neutrophil CD62L expression 281 (253–300) 292 (257–356) 0.43
Neutrophil CD11b expression 478 (276–621) 462 (237–594) 0.65
24 h postoperative
Monocyte count 1.4 (1.0-2.2) 0.9 (0.7-1.3) 0.29
% CD16- monocytes 88 (78–94) 81 (73–91) 0.23
% CD16int monocytes 10 (6.0-21) 10 (6.0-26) 0.61
% CD16+ monocytes 2.9 (1.7-3.0) 6.0 (3.0-7.0) 0.01
Neutrophil count 11 (9.0-16) 8.8 (7.0-15) 0.32
Neutrophil CD62L expression 260 (196–322) 300 (227–336) 0.35
Neutrophil CD11b expression 359 (227–491) 288 (176–368) 0.22
Cytokines and chemokines
4 h postoperative
IL-1β 0.25 (0.25-0.25) 0.25 (0.25-4.2) 0.61
IL-6 91 (48–114) 49 (41–65) 0.14
IL-8 77 (59–109) 53 (29–64) 0.04
IL-10 2760 (2474–7077) 3112 (768–5758) 0.42
24 h postoperative
IL-1β 0.25 (0.00-3.9) 2.2 (0.51-3.5) 0.48
IL-6 19 (11–34) 23 (7.6-33) 0.76
IL-8 44 (27–67) 15 (11–37) 0.05
IL-10 24 (16–33) 15 (7.4-31) 0.20
Values represent medians (interquartile ranges). Neutrophil and monocyte counts in 109/L, neutrophil expressions in median fluorescence intensity (MFI), cytokine
and chemokine concentrations in pg/ml. ACP, antegrade cerebral perfusion; DHCA, deep hypothermic circulatory arrest.
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Figure 2, neutrophil and monocyte concentrations were
much lower than may be expected due to the expansion of
the circulating volume by connection to the CPB circuit.
Hence, cells may be migrating out of the circulation in re-
sponse to another, as yet unknown, trigger. At this point,
these cells may occupy the perivascular space, only to be
released again promptly after cerebral ischemia has
occurred.
Regarding the soluble effects of cerebral ischemia, al-
though subtle, significant differences were found after
DHCA in IL-6 and sVCAM-1. The higher IL-6 concentra-
tion in venous blood after DHCA is presumably a direct
effect of ischemia on the endothelium and the intra- and
perivascular leukocytes. In line with the activated pheno-
types of neutrophils and monocytes, these may rapidly re-
lease vast amounts of IL-6. The lower sVCAM-1
concentration may represent the uptake of sVCAM by
these cells, as their activated subsets are known to highly
express the receptor CD49d [8].
We cannot predict if the observed changes in inflamma-
tion are of any clinical relevance. Generally, a more proin-
flammatory milieu in the first hours of reperfusion
predisposes to a more detrimental cerebral outcome
[5,35]. However, the difference in inflammation between
DHCA and ACP was limited to the time point immedi-
ately after the insult, suggesting that the effect of the is-
chemia was temporary. Of note, this may only be the case
in this specific context, as the effect of other inflammatory
triggers during surgery (such as the ongoing surgical dam-
age, the use of CPB and cyanosis) are likely overwhelming
[36,37].
We acknowledge that this work has important limita-
tions. First, this is a model of cerebral ischemia during
deep hypothermia, a temperature not directly applicable
to the clinical situation in which adults or children have a
stroke. Similarly, although still a matter of debate, neo-
nates may have a different permeability of the blood–brain
barrier than adults [38,39]. Second, as dexamethasone was
administered to all patients before the start of CPB, we
cannot exclude that this may have mitigated the inflam-
matory response to the ischemia [40]. Finally, due to the
many triggers for systemic inflammation that accompany
the surgery of these patients, later effects of the ischemia
are impossible to tease out. In an animal model, a more
‘clean’ model of cerebral ischemia can be performed, and
the evolution of the inflammation can be studied at all
desired time points. However, the translation to the
human situation is fraught with difficulties, making studies
like the current study essential to gain insight into these
complex mechanisms.
Conclusions
In neonates undergoing cardiac surgery at deep hy-
pothermia, we observed an enhanced innate immune
response immediately after cerebral ischemia. Most not-
ably, a high number of activated neutrophils and mono-
cytes were found exiting the cerebral circulation.
Although the findings are not extreme, this is the first
report of such a phenomenon in the very early period
after cerebral ischemia and it may hold important clues
for the understanding of the immune response to stroke.
Further investigation is needed to determine the under-
lying mechanisms and the further consequences of this
rapid immune response, as a better understanding can
hold clues for new biomarkers and potentially novel
therapeutic options.
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